文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

ICU幸存者出院时中枢作用药物负荷对长期结局的影响

The Impact of Centrally Acting Drug Burden at Discharge on Long-Term Outcomes Among ICU Survivors.
PubMed 文献 · Crit Care Med · 2026-06-09
一句话结论在ICU幸存者中,出院时药物负荷指数所测的中枢作用药物负荷与长期认知障碍、躯体残疾或90天死亡率无显著关联。

该研究为三项前瞻性队列研究的子研究,纳入 tertiary academic medical center 中因呼吸衰竭和/或休克存活出ICU的成年患者。使用药物负荷指数(DBI)在入院、转入ICU和出院时量化药物负荷,认知用验证过的认知测试组合评估,躯体残疾用Katz日常生活活动能力(ADL)和功能活动问卷(FAQ)评估,90天死亡率通过病历回顾和代理人获取。共纳入676例患者,其中478例有认知评估数据,490例有躯体评估数据;DBI中位数在入院、转入ICU和出院时分别为1.96、2.42和3.08。出院DBI与长期认知障碍(OR 1.25;95%CI 0.89-1.76;P=0.20)、Katz ADL(OR 1.08;95%CI 0.80-1.44;P=0.62)、FAQ(OR 1.15;95%CI 0.89-1.49;P=0.29)及90天死亡率(HR 0.87;95%CI 0.61-1.23;P=0.42)均无统计学显著关联。

要点

  • 在676例ICU幸存者中,出院时DBI与长期认知障碍无显著关联(OR 1.25;95%CI 0.89-1.76;P=0.20)。
  • 出院DBI与Katz ADL躯体残疾无显著关联(OR 1.08;95%CI 0.80-1.44;P=0.62)。
  • 出院DBI与FAQ评估的躯体残疾无显著关联(OR 1.15;95%CI 0.89-1.49;P=0.29)。
  • 出院DBI与90天死亡率无显著关联(HR 0.87;95%CI 0.61-1.23;P=0.42)。
  • DBI中位数从入院1.96升至转入ICU 2.42和出院3.08,提示住院期间中枢作用药物负荷增加。

适用人群与场景

  • 成人ICU患者,因呼吸衰竭和/或休克存活出ICU者。

研究设计与关键结果

  • 研究设计:三项前瞻性队列研究的子研究,单中心(tertiary academic medical center),共纳入676例ICU幸存者,其中478例有认知评估数据,490例有躯体评估数据。
  • 暴露:使用药物负荷指数(DBI)在入院、转入ICU和出院时量化中枢作用药物负荷;DBI中位数分别为1.96、2.42和3.08。
  • 主要终点:出院DBI与长期认知障碍无显著关联(OR 1.25;95%CI 0.89-1.76;P=0.20)。
  • 次要终点:出院DBI与Katz ADL无显著关联(OR 1.08;95%CI 0.80-1.44;P=0.62);与FAQ无显著关联(OR 1.15;95%CI 0.89-1.49;P=0.29);与90天死亡率无显著关联(HR 0.87;95%CI 0.61-1.23;P=0.42)。

证据类型、等级与局限

  • 证据类型:三项前瞻性队列研究的子研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:在该ICU幸存者队列中,未发现DBI所测中枢作用药物负荷与长期认知障碍、躯体残疾或90天死亡率存在显著关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: ICU patients are at increased risk of inappropriate prescribing and high drug burden. These patients also often experience cognitive impairment, physical disability, and increased mortality after discharge. We investigated whether drug burden at hospital discharge was associated with worsened cognition, physical disability, and mortality among ICU survivors up to 6 months postdischarge.

DESIGN: Substudy of three prospective cohort studies.

SETTING: Tertiary academic medical center.

PATIENTS: Adult patients with respiratory failure and/or shock discharged alive from the ICU.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Drug burden was quantified using drug burden index (DBI) at admission, ICU transfer, and hospital discharge. Cognition was assessed with validated cognitive batteries. We assessed physical disability using Katz activities of daily living (ADL) and Functional Activities Questionnaire (FAQ), and 90-day mortality via chart review and surrogate. Binary logistic regression was used to investigate the association of discharge DBI on cognitive impairment, adjusting for prespecified covariates. Multivariable proportional odds logistic regression was used to investigate the association of discharge DBI on physical disability. Cox proportional hazards regression was used to investigate 90-day mortality. A total of 676 patients were included, 478 patients with cognitive assessment and 490 with physical assessment data. Median DBI increased throughout hospitalization with admission, ICU transfer, and hospital discharge DBI 1.96, 2.42, and 3.08, respectively. We did not find a statistically significant association between hospital discharge DBI and long-term cognitive impairment (odds ratio [OR] 1.25; 95% CI, 0.89-1.76; p = 0.20). There was no association between hospital discharge DBI and Katz activities of daily living (OR 1.08; 95% CI, 0.80-1.44; p = 0.62), FAQ (OR 1.15; 95% CI, 0.89-1.49; p = 0.29), or 90-day mortality (hazard ratio 0.87; 95% CI, 0.61-1.23; p = 0.42).

CONCLUSIONS: Within our cohort of ICU survivors, we did not find a significant association of centrally acting drug burden measured by the DBI with long-term cognitive impairment, physical disability, or 90-day mortality.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Boncyk C, Connell J, Stollings JL, et al. The Impact of Centrally Acting Drug Burden at Discharge on Long-Term Outcomes Among ICU Survivors. Crit Care Med. 2026. PMID: 42262347. doi:10.1097/CCM.0000000000007225

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。